InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference
InspireMD (Nasdaq: NSPR), the developer of CGuard™ Prime carotid stent system for carotid artery disease treatment and stroke prevention, has announced its participation in the upcoming 24th Annual Needham Virtual Healthcare Conference.
The presentation is scheduled for Wednesday, April 9, 2025, at 8:00AM Eastern Time / 5:00AM Pacific Time. Investors and interested parties can access a live audio webcast of the presentation, with a replay available for 90 days through the company's website at inspiremd.com in the News & Events section.
InspireMD (Nasdaq: NSPR), sviluppatore del sistema di stent carotideo CGuard™ Prime per il trattamento della malattia dell'arteria carotidea e la prevenzione degli ictus, ha annunciato la sua partecipazione alla prossima 24ª Conferenza Virtuale sulla Salute Annuale di Needham.
La presentazione è programmata per mercoledì 9 aprile 2025, alle 8:00 AM ora orientale / 5:00 AM ora pacifica. Gli investitori e le parti interessate possono accedere a una trasmissione audio in diretta della presentazione, con una registrazione disponibile per 90 giorni sul sito web dell'azienda all'indirizzo inspiremd.com nella sezione Notizie ed Eventi.
InspireMD (Nasdaq: NSPR), desarrollador del sistema de stent carotídeo CGuard™ Prime para el tratamiento de la enfermedad de la arteria carótida y la prevención de accidentes cerebrovasculares, ha anunciado su participación en la próxima 24ª Conferencia Virtual Anual de Atención Médica de Needham.
La presentación está programada para el miércoles 9 de abril de 2025, a las 8:00 AM hora del este / 5:00 AM hora del pacífico. Los inversores y partes interesadas pueden acceder a una transmisión en vivo de audio de la presentación, con una repetición disponible durante 90 días a través del sitio web de la empresa en inspiremd.com en la sección de Noticias y Eventos.
InspireMD (Nasdaq: NSPR)는 경동맥 질환 치료 및 뇌졸중 예방을 위한 CGuard™ Prime 경동맥 스텐트 시스템의 개발업체로, 다가오는 제24회 니드햄 가상 의료 회의에 참여한다고 발표했습니다.
발표는 2025년 4월 9일 수요일 오전 8:00 동부 표준시 / 오전 5:00 태평양 표준시에 예정되어 있습니다. 투자자와 관심 있는 당사자는 발표의 실시간 오디오 웹캐스트에 접근할 수 있으며, 회사 웹사이트 inspiremd.com의 뉴스 및 이벤트 섹션을 통해 90일 동안 재생할 수 있습니다.
InspireMD (Nasdaq: NSPR), développeur du système de stent carotidien CGuard™ Prime pour le traitement des maladies de l'artère carotide et la prévention des AVC, a annoncé sa participation à la prochaine 24e Conférence Virtuelle Annuelle de Santé de Needham.
La présentation est prévue pour le mercredi 9 avril 2025, à 8h00, heure de l'Est / 5h00, heure du Pacifique. Les investisseurs et les parties intéressées peuvent accéder à un webinaire audio en direct de la présentation, avec un replay disponible pendant 90 jours sur le site web de l'entreprise à inspiremd.com dans la section Actualités et Événements.
InspireMD (Nasdaq: NSPR), Entwickler des CGuard™ Prime Carotisstent-Systems zur Behandlung von Karotisarterienerkrankungen und zur Schlaganfallprävention, hat seine Teilnahme an der bevorstehenden 24. jährlichen virtuellen Gesundheitskonferenz von Needham angekündigt.
Die Präsentation ist für Mittwoch, den 9. April 2025, um 8:00 Uhr Eastern Time / 5:00 Uhr Pacific Time geplant. Investoren und Interessierte können auf einen Live-Audio-Webcast der Präsentation zugreifen, mit einer Wiederholung, die 90 Tage lang über die Unternehmenswebsite inspiremd.com im Bereich Nachrichten und Veranstaltungen verfügbar ist.
- None.
- None.
MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced management will present at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, at 8:00AM Eastern Time / 5:00AM Pacific Time.
A live audio webcast and replay of the presentation may be accessed for 90 days on the “News & Events” section of the company’s website at: https://www.inspiremd.com/en/events/
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com
Webb Campbell
Gilmartin Group LLC
webb@gilmartinir.com
investor-relations@inspiremd.com
FAQ
When is InspireMD (NSPR) presenting at the Needham Healthcare Conference 2025?
How long will the NSPR Needham Conference presentation replay be available?
What is the main product InspireMD (NSPR) is developing?
Where can investors access InspireMD's (NSPR) Needham Conference presentation?
